Fibrinogen Human Completed Phase 2 Trials for Bleeding (Oozing) in Hepatic Resection Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01244425Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection